Huma Therapeutics is a global digital health technology company headquartered in the UK that advances digital-first care delivery and research to help people live longer, fuller lives. Huma's award-winning modular platforms are used by more than 3,000 hospitals and clinics, with 1.8 million active users. Huma's offering works across different disease areas and powers: Hospitals at Home, Software as a Medical Device (SaMD) solutions and DCT platform to support digital or hybrid studies. Huma's platform has been shown to almost double clinical capacity, reduce readmissions by over a third, enable better diversity, participant retention and protocol adherence, whilst allowing trials to run within weeks.